Aeterna Zentaris Inc is a specialty biopharmaceutical company based in Summerville, SC, focused on the development and commercialization of innovative therapies. With a diverse product pipeline and a strong emphasis on therapeutic and diagnostic development, Aeterna Zentaris aims to address unmet medical needs and improve patient outcomes.
The company's flagship product, Macimorelin DX, is temporarily discontinued in the US commercial market for the diagnosis of adult growth hormone deficiency (AGHD), pending a re-launch with an alternate commercialization partner. Aeterna Zentaris is actively seeking strategic development and commercialization partnerships to further advance its pipeline and bring novel treatments to patients in need.
Generated from the website